Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

PLC-inhibitory peptides from Kyowa Hakko

April 22, 1997

Inflazyme licences anticancer drugs

April 21, 1997

Antimetastatic activity of Neovastat reported at AACR meeting

April 21, 1997

Antitumor/antibacterial agent isolated by Microbial Chemistry Research Foundation

April 21, 1997

Mercian discloses novel anthracycline antibiotics

April 21, 1997

Agouron anticancer research presented at AACR

April 21, 1997

Vertex and BioChem Pharma test VX-710 for breast cancer and soft tissue sarcoma

April 21, 1997

German launch for Femara

April 21, 1997

PDT expands phase II/III trial of Purlytin

April 18, 1997

Anti-CD44 antisense oligonucleotides prepared by ICN

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.